Stocks
AxoGen Financial Statements (AXGN) |
||||||||||
| AxoGensmart-lab.ru | % | 2021 | 2022 | 2022 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 25.02.2022 | 30.09.2022 | 14.03.2023 | 01.05.2023 | 05.03.2024 | 07.11.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 127.4 | 138.6 | 138.6 | 159.0 | 180.9 | ||||
| Operating Income, bln rub | -25.4 | -29.7 | -29.7 | -21.5 | -8.50 | |||||
| EBITDA, bln rub | ? | -20.9 | -25.1 | -23.5 | -13.3 | 1.02 | ||||
| Net profit, bln rub | ? | -28.1 | -27.3 | -27.3 | -21.7 | -14.3 | ||||
| OCF, bln rub | ? | -13.4 | -16.1 | -16.1 | -5.72 | -4.41 | ||||
| CAPEX, bln rub | ? | 28.4 | 21.3 | 21.3 | 14.9 | 4.49 | ||||
| FCF, bln rub | ? | -41.8 | -37.3 | -37.3 | -20.6 | -8.62 | ||||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
| OPEX, bln rub | 129.8 | 144.1 | 144.1 | 149.3 | 146.7 | |||||
| Cost of production, bln rub | 22.9 | 24.1 | 24.1 | 31.1 | 42.7 | |||||
| R&D, bln rub | 24.2 | 27.2 | 27.2 | 28.3 | 28.4 | |||||
| Interest expenses, bln rub | 1.36 | 0.624 | 0.624 | 2.84 | 8.29 | |||||
| Assets, bln rub | 208.0 | 195.5 | 195.4 | 195.4 | 196.8 | 192.0 | ||||
| Net Assets, bln rub | ? | 112.6 | 101.4 | 101.0 | 101.0 | 95.7 | 99.4 | |||
| Debt, bln rub | 67.5 | 67.7 | 67.4 | 67.4 | 69.3 | 68.9 | ||||
| Cash, bln rub | 84.1 | 53.1 | 48.8 | 48.8 | 37.0 | 18.7 | ||||
| Net debt, bln rub | -16.6 | 14.5 | 18.6 | 18.6 | 32.3 | 50.2 | ||||
| Ordinary share price, rub | 9.37 | 11.9 | 9.98 | 9.98 | 6.83 | 3.79 | ||||
| Number of ordinary shares, mln | 41.2 | 42.1 | 42.1 | 42.9 | 43.9 | |||||
| Market cap, bln rub | 386 | 0 | 420 | 420 | 293 | 166 | ||||
| EV, bln rub | ? | 370 | 15 | 439 | 439 | 325 | 217 | |||
| Book value, bln rub | 110 | 98 | 97 | 97 | 91 | 94 | ||||
| EPS, rub | ? | -0.68 | -0.65 | -0.65 | -0.51 | -0.33 | ||||
| FCF/share, rub | -1.01 | -0.89 | -0.89 | -0.48 | -0.20 | |||||
| BV/share, rub | 2.66 | 2.31 | 2.31 | 2.13 | 2.15 | |||||
| EBITDA margin, % | ? | -16.4% | -18.1% | -16.9% | -8.38% | 0.57% | ||||
| Net margin, % | ? | -22.0% | -19.7% | -19.7% | -13.7% | -7.91% | ||||
| FCF yield, % | ? | -10.8% | 0.00% | -8.89% | -8.89% | -7.05% | -5.18% | |||
| ROE, % | ? | -24.9% | 0.00% | -27.1% | -27.1% | -22.7% | -14.4% | |||
| ROA, % | ? | -13.5% | 0.00% | -14.0% | -14.0% | -11.0% | -7.45% | |||
| P/E | ? | -13.8 | -15.4 | -15.4 | -13.5 | -11.6 | ||||
| P/FCF | -9.24 | -11.3 | -11.3 | -14.2 | -19.3 | |||||
| P/S | ? | 3.03 | 3.03 | 3.03 | 1.84 | 0.92 | ||||
| P/BV | ? | 3.52 | 0.00 | 4.31 | 4.31 | 3.21 | 1.77 | |||
| EV/EBITDA | ? | -17.7 | -17.5 | -18.7 | -24.4 | 211.6 | ||||
| Debt/EBITDA | 0.80 | -0.74 | -0.79 | -2.42 | 49.1 | |||||
| R&D/CAPEX, % | 85.1% | 127.8% | 127.8% | 189.9% | 631.4% | |||||
| CAPEX/Revenue, % | 22.3% | 15.3% | 15.3% | 9.38% | 2.48% | |||||
| AxoGen shareholders | ||||||||||
